Effects of Idazoxan on Alcohol Pharmacokinetics and Intoxication: A Preliminary Human Laboratory Study

Background Preliminary basic and human studies suggest that the α2-adrenergic antagonist idazoxan may represent a novel medication for alcohol dependence (AD). The goal of this study was to evaluate the safety and tolerability of the co-administration of idazoxan with alcohol and explore whether pharmacokinetics (PK) and biobehavioral (Pharmacodynamics, PD) mechanisms of idazoxan may alter alcohol's effects.